Ancillary Studies to the Ad Neuroimaging Initiative

Document Type:	Grants Notice
Funding Opportunity Number:	PA-04-158
Posted Date:	Sep 29, 2004
Original Due Date for Applications:	Multiple Receipt Dates - See Link to Full Announcement for details.
Current Due Date for Applications:	Multiple Receipt Dates - See Link to Full Announcement for details.
Archive Date:	Dec 01, 2007
Funding Instrument Type:	Grant
Category of Funding Activity:	Health
Expected Number of Awards:	Not Available.
Estimated Total Program Funding:	Not Available.
Award Ceiling:	$50,000.00
Award Floor:	none
CFDA Number:	93.286 -- Discovery and Applied Research 93.866 -- Aging Research
Cost Sharing or Matching Requirement:	No

Eligible Applicants

Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

For profit organizations other than small businesses

Small businesses

Public and State controlled institutions of higher education

Private institutions of higher education

State governments

County governments

City or township governments

Special district governments

Independent school districts

Native American tribal governments (Federally recognized)

Public housing authorities/Indian housing authorities

Native American tribal organizations (other than Federally recognized tribal governments)

Others (see text field entitled "Additional Information on Eligibility" for clarification)

Additional Information on Eligibility:

Eligible agencies of the Federal Government are eligible to apply.
Foreign institutions are eligible to apply.

Agency Name

Description

This PA invites research grant applications for ancillary studies to the Alzheimers Disease Neuroimaging Initiative (ADNI), a multi-site, longitudinal, prospective, naturalistic study of normal cognitive aging, mild cognitive impairment (MCI), and early Alzheimer's disease (AD). The ADNI will collect, process, and store serial blood, CSF, and urine samples in the three groups for analyses for potential biomarkers of disease progression, including genomic, proteomic, and metabolomic markers that can be correlated with clinical, neuropsychological, and imaging data. Immortalized cell lines will also be established.

The ancillary studies may propose and measure potential biomarkers, or offer new approaches to analyzing the dataset (e.g., image processing techniques, statistical analysis), or develop parallel neuroimaging studies with a different sample but with a subset of the measures used in the ADNI protocol, or propose autopsy studies.

Link to Full Announcement

http://grants.nih.gov/grants/guide/pa-files/PA-04-158.html

If you have difficulty accessing the full announcement electronically, please contact:

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster NIH OER Webmaster

• HHS NIH listed by [Posted Date]
• HHS Agencywide listed by [Posted Date]